FDA Adverse Event Malfunction Summary report: N

KOH-EFFICIENT, RUMI 3.5CM

MDR report key: 3072603 · Received April 19, 2013

Report

Report Number
1627186-2013-00005
Event Type
Malfunction
Date Received
April 19, 2013
Date of Event
March 18, 2013
Report Date
April 19, 2013
Manufacturer
COOPERSURGICAL, INC.
Product Code
KOH
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CT, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DHR REVIEW OF LOT# 138986 SHOWS ALL PRODUCTS WERE MANUFACTURED AND TESTED PER ESTABLISHED PROCEDURES AND THERE WERE NO SIGNIFICANT ISSUES IDENTIFIED EITHER DURING MANUFACTURING, ASSEMBLY OR TESTING. RECEIVING INSPECTIONS PERFORMED ON COMPONENT LOTS OF KOH CUPS, SLEEVES, SLEEVE EXTENSIONS AND HINGE ADAPTORS ALSO DID NOT SHOW ANY SIGNIFICANT ISSUES. COOPERSURGICAL'S CHIEF MEDICAL OFFICER SPOKE TO DR (B)(6) REGARDING THE EVENT. HIS ANALYSIS STATES "GIVEN THAT THE BLEEDING OCCURRED DURING THE MANIPULATION PHASE AND THE LACERATION WAS AT THE APEX OF THE VAGINA, IT IS LIKELY THAT THE TORQUE NEEDED TO EXPOSE THE VASCULATURE IN THIS BROAD UTERUS CAUSED THE LEADING EDGE OF THE KOH CUP TO TEAR AGAINST THE VAGINAL TISSUE WITH STROPHY CONTRIBUTING TO THIS TEAR. ALTHOUGH PERHAPS THE 3.5 CUP WAS CORRECT IN SIZE, THIS IS A LARGE DIAMETER FOR THE AVERAGE (B)(6) PATIENT - BUT EVERY OPERATIVE ANATOMY CAN BE DIFFERENT. THERE IS NO SUGGESTION THAT THE KOH EFFICIENT SLEEVE OR HINGE CONTRIBUTED TO THE EVENT - THE TIMING AND LOCATION OF THE LACERATION ALSO SPEAKS AGAINST ANY CONTRIBUTION OF THE SLEEVE PORTION OF THE DEVICE." (B)(4).

Description of Event or Problem · 1

PHYSICIAN PERFORMED A ROBOTIC TOTAL HYSTERECTOMY ON A (B)(6) WOMAN. AT THE END OF THE PROCEDURE, THE PHYSICIAN NOTED EXCESSIVE VAGINAL BLEEDING AND 2 LACERATIONS ON EACH SIDE. THE PATIENT REQUIRED SUTURES AND 3 UNITS OF BLOOD.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
170658 KOH-EFFICIENT, RUMI 3.5CM NONE KOH COOPERSURGICAL, INC. 138986

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention